iifl-logo-icon 1

Hindustan Bio Sciences Ltd Share Price

8.24
(-1.44%)
Jul 3, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open8.23
  • Day's High8.49
  • 52 Wk High15.18
  • Prev. Close8.36
  • Day's Low8.1
  • 52 Wk Low5.15
  • Turnover (lac)1.82
  • P/E137.33
  • Face Value2
  • Book Value0.78
  • EPS0.06
  • Mkt. Cap (Cr.)8.45
  • Div. Yield0
No Records Found

Hindustan Bio Sciences Ltd KEY RATIOS

Sector

Trading

CMP
as on 03 Jul, 2024 12:00:00 AM

8.24 --1.44 --0.12

Open

8.23

Prev. Close

8.36

Turnover(Lac.)

1.82

Day's High

8.49

Day's Low

8.1

52 Week's High

15.18

52 Week's Low

5.15

Book Value

0.78

Face Value

2

Mkt Cap (₹ Cr.)

8.45

P/E

137.33

EPS

0.06

Divi. Yield

0

Hindustan Bio Sciences Ltd Corporate Action

10 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

4 Dec 2023

12:00 AM

EGM

arrow

31 Jul 2023

12:00 AM

AGM

Announcement Date: 31 Jul, 2023

arrow

Hindustan Bio Sciences Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Hindustan Bio Sciences Ltd SHAREHOLDING SNAPSHOT

03 Jul, 2024|11:58 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 12.19%

Foreign: 0.00%

Indian: 12.19%

Non-Promoter- 87.80%

Institutions: 0.00%

Non-Institutions: 87.80%

Custodian: 0.00%

Share Price

Hindustan Bio Sciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

2.05

10.25

10.25

10.25

Preference Capital

0

0

0

0

Reserves

-1.3

-9.46

-8.95

-8.01

Net Worth

0.75

0.78

1.3

2.24

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

1.03

1.94

1.03

1.01

yoy growth (%)

-46.89

88.46

1.84

-19.64

Raw materials

-0.68

-1.3

-0.56

-0.72

As % of sales

65.93

66.92

55.04

71.82

Employee costs

-0.24

-0.25

-0.22

-0.26

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-0.95

0.11

-2.27

-0.48

Depreciation

0

-0.01

0

-0.01

Tax paid

0.01

-0.03

0

0

Working capital

-0.87

1.25

0.09

-0.13

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-46.89

88.46

1.84

-19.64

Op profit growth

-791.35

-105.78

404.59

278.8

EBIT growth

-860.9

-105.49

376.04

255.53

Net profit growth

-1,262.13

-103.55

362.89

-76.45

View Ratios

No Record found

Hindustan Bio Sciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

3,150

128.63,59,168.75776.710.049,210.18145.96

Aegis Logistics Ltd

AEGISLOG

859.6

73.729,903.45125.880.38721.5167.87

Cello World Ltd

CELLO

918.55

308.4219,113.5318.620.17260.7733.59

Redington Ltd

REDINGTON

219.95

15.8217,105.22160.57010,490.2446.35

Honasa Consumer Ltd

HONASA

436.9

116.4614,085.1726.710427.1734.67

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Hindustan Bio Sciences Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

J.V.R. Mohan Raju

Independent Director

B R Rao

Non Executive Director

J Uma

Independent Director

K Rama Chandra Raju

Independent Director

M Satyanarayana Raju

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991. The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates.Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd.The Company acquired the shares of Venkar Chemicals Ltd in 2004 and consequently upon acquisition, it became Wholly owned subsidiary of the Company with effect from 19.08.2004.During 2006-07, Company got approval from Drugs Controller General of India (DCGI) and started marketing the nephrology product Recombinant Human Erythropoietin with the brand name EPOVIN from June, 2007.The Company to its credit has world class manufacturing facilities for dry and liquid injectables, liquid/dry syrups, Eye/Ear/Nasal drops, pre-filled syringes and non sterile/sterile ointments, tablets and capsules
Read More

Company FAQs

What is the Hindustan Bio Sciences Ltd share price today?

Down Arrow

The Hindustan Bio Sciences Ltd shares price on nse is Rs.₹8.24 today.

What is the Market Cap of Hindustan Bio Sciences Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Hindustan Bio Sciences Ltd is ₹8.45 Cr. as of 03 Jul ‘24

What is the PE and PB ratio of Hindustan Bio Sciences Ltd?

Down Arrow

The PE and PB ratios of Hindustan Bio Sciences Ltd is 137.33 and 10.56 as of 03 Jul ‘24

What is the 52 Week High and Low of Hindustan Bio Sciences Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Hindustan Bio Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Hindustan Bio Sciences Ltd is ₹5.15 and ₹15.18 as of 03 Jul ‘24

What is the CAGR of Hindustan Bio Sciences Ltd?

Down Arrow

Hindustan Bio Sciences Ltd's CAGR for 5 Years at 54.82%, 3 Years at 31.94%, 1 Year at 13.43%, 6 Month at -10.40%, 3 Month at 19.94% and 1 Month at 2.96%.

What is the shareholding pattern of Hindustan Bio Sciences Ltd?

Down Arrow

The shareholding pattern of Hindustan Bio Sciences Ltd is as follows:
Promoters - 12.19 %
Institutions - 0.00 %
Public - 87.81 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.